Center for Energy Studies Providing new insights on the role of economics, policy and regulation in the performance and evolution of energy markets. More Details
Center for Health and Biosciences Advancing data-based policies that promote health and well-being in the U.S. and around the world. More Details
Edward P. Djerejian Center for the Middle East Developing pragmatic policy approaches to the region’s enduring political, economic and societal concerns. More Details
Center for Public Finance Delivering research and analysis on the effects of major U.S. fiscal policies. More Details
Center for the U.S. and Mexico Strengthening the binational relationship by addressing major concerns on both sides of the border. More Details
McNair Center for Entrepreneurship and Economic Growth Providing actionable policy analysis and recommendations that aim to expand the economy through private enterprise. More Details
China Studies Analyzing the influence of the transnational circulation of people, technologies, commodities and ideas in China. Read More
Drug Policy Pursuing research and open debate to develop pragmatic drug policies based on common sense and driven by human rights interests. Read More
International Economics Studying timely issues in global economic policy as well as developmental policy in foreign countries. Read More
Presidential Elections Offering nonpartisan analysis of elections to better understand the changing dynamics of presidential campaigns. Read More
Religion and Public Policy Exploring how religion and cultural factors interact with public policy issues. Read More
Science and Technology Policy Addressing a broad range of policy issues that affect scientists and their research. Read More
Center for Energy Studies Wed, Oct. 05, 2022 | 9 am - 10:30 am Webinar — Energy Market Update: Winter Is Coming See Details
Center for the U.S. and Mexico Fri, Oct. 07, 2022 | 11 am - 12 pm Mexico 2025 and Beyond: A Conversation with Leo Zuckermann See Details
Conflict Resolution and U.S. Foreign Policy Thu, Oct. 13, 2022 | 12 pm - 1 pm How Cold War History Can Help — and Hinder — Our Understanding of Russia's War on Ukraine See Details
Join the Roundtable Learn more about the Baker Institute’s premier membership forum, which offers unique opportunities to engage with fellows and policy-minded peers. Read More
Join the RT Young Professionals If you're interested in major political and public policy issues, and want the opportunity to network with industry leaders and your peers, then our young professionals organization is for you. Read More
Major Gifts Major gifts provide the funds necessary for the Baker Institute to explore new areas of study and research, and expand current programs. Read More
Endowments Endowment gifts provide the Baker Institute with permanent resources that support research programs, fellows and scholars. Read More
Planned Giving Plan a gift that will ensure lasting, meaningful support for policy programs important to you. Read More
Corporate Support Corporations can become involved with the institute in a number of ways and see the benefit from the research conducted by our fellows and scholars. Read More
People Learn more about the Baker Institute's leadership and get contact information for the administrative staff. Read More
Student Opportunities Through the internships on campus and beyond, Rice students can explore careers in public policy, or simply become better informed about important issues of the day. Read More
Contact Us Complete a form for event, media or other inquiries, and get directions and parking information for the Baker Institute. Read More
Center for Health and Biosciences | Biomedical Research | Op-Ed With experimental drugs, 'right to try' can go wrong July 29, 2016 | Kirstin R.W. Matthews toggle sidebar Toggle Sidebar Table of Contents Author(s) Kirstin R.W. Matthews Fellow in Science and Technology Policy Share this Publication Facebook Twitter Email Linkedin Print This Publication Tags right to try lawclinical trials By Kirstin R.W. Matthews and Michelle Rubin Access to experimental drugs by terminally ill patients is a highly contested topic. Authors discuss the benefits and consequences of "right to try" laws, which grant patient access to such drugs. TribTalk: http://bit.ly/2akfGKR Print This Publication Share Facebook Twitter Email Linkedin Related Research Center for Health and Biosciences | Science and Technology Policy | Domestic Health Policy Analysis | Report A New Weapon in the Anti-Vaccine Arsenal: Claiming the Unvaccinated as a Protected Class Read More Center for Health and Biosciences | Domestic Health Policy Analysis | Report Estimating the Potential Profit Gains from Lowering Employee Health Care Costs for America’s Largest Companies Read More Science and Technology Policy | Center for Health and Biosciences | Issue Brief Vaccine Hesitancy and Resistance in Texas: An Analysis of Testimony from the 2021 Texas State Legislative Session Read More Back to top
Center for Health and Biosciences | Science and Technology Policy | Domestic Health Policy Analysis | Report A New Weapon in the Anti-Vaccine Arsenal: Claiming the Unvaccinated as a Protected Class Read More
Center for Health and Biosciences | Domestic Health Policy Analysis | Report Estimating the Potential Profit Gains from Lowering Employee Health Care Costs for America’s Largest Companies Read More
Science and Technology Policy | Center for Health and Biosciences | Issue Brief Vaccine Hesitancy and Resistance in Texas: An Analysis of Testimony from the 2021 Texas State Legislative Session Read More
